ACAD - ACADIA Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACAD is currently covered by 24 analysts with an average price target of $23.4. This is a potential upside of $7.09 (43.47%) from yesterday's end of day stock price of $16.31.

ACADIA Pharmaceuticals's activity chart (see below) currently has 313 price targets and 282 ratings on display. The stock rating distribution of ACAD is 34.02% HOLD, 64.95% BUY and 1.03% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.36% with an average time for these price targets to be met of 211.28 days.

Highest price target for ACAD is $42, Lowest price target is $19, average price target is $23.4.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 07-Nov-2024. First documented stock forecast 06-May-2013.

Currently out of the existing stock ratings of ACAD, 33 are a HOLD (34.02%), 63 are a BUY (64.95%), 1 are a SELL (1.03%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$27

$10.58 (64.43%)

$27

13 days ago
(07-Nov-2024)

8/22 (36.36%)

$9.79 (56.89%)

119

Buy

$28

$11.58 (70.52%)

$28

13 days ago
(07-Nov-2024)

0/4 (0%)

$10.79 (62.70%)

Hold

1 months 10 days ago
(10-Oct-2024)

11/14 (78.57%)

$9.98 (39.89%)

141

Buy

$23

$6.58 (40.07%)

$30

3 months 12 days ago
(08-Aug-2024)

0/3 (0%)

$7.28 (46.31%)

Buy

$20

$3.58 (21.80%)

$28

3 months 13 days ago
(07-Aug-2024)

16/21 (76.19%)

$4.83 (31.84%)

184

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?

On average it took 211.28 days on average for the stock forecasts to be realized with a an average price target met ratio 66.36

Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?

Cory Kasimov works at EVERCORE and has 5 price targets and 5 ratings on ACAD

Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?

Alan Carr with highest potential upside - $43.58

Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?

Salveen Richter with lowest potential downside - -$4.42

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?